cvs - Search News

News

CVS, HIV and Drug Yeztugo

CVS Health denies coverage for breakthrough HIV drug, committing 'clear violation' of ACA

CVS Health will not cover Gilead's Yeztugo, generic name lenacapavir (LEN), citing "clinical, financial, and regulatory factors."

Reuters on MSN · 1d

Exclusive: CVS holds off adding Gilead’s new HIV prevention shot to drug coverage lists

CVS Health , which runs the largest U.S. pharmacy benefit manager, will not add Gilead Sciences' new HIV prevention drug to its commercial plans for now, a spokesperson told Reuters, despite the medicine's proven effectiveness.

Zacks Investment Research on M… · 6h

GILD Stock Slips as CVS Health Excludes New HIV Drug Yeztugo

Shares of Gilead Sciences, Inc. (GILD) tumbled 2.2% on Aug. 21, after pharmacy benefit manager CVS Health (CVS) decided not to add the former’s new HIV prevention drug, Yeztugo (lenacapavir), to its commercial plans for now.

1don MSN

CVS Caremark ordered to pay $290M after Medicare fraud scheme exposed by former Aetna whistleblower

Whistleblower Sarah Behnke's lawsuit leads to a $290 million judgment against CVS Caremark for overcharging Medicare on ...

2don MSN

CVS unit must pay $290 million in drug whistleblower lawsuit, judge rules

A federal judge ordered CVS Health's pharmacy benefit manager unit to pay $289.9 million in damages and penalties after it ...

Becker's Hospital Review1d

CVS Caremark ordered to pay $290M in false claims suit

A federal judge has ordered CVS Caremark to pay nearly $290 million in damages after determining the pharmacy benefit manager overbilled Medicare for prescription drugs, according to court documents ...

2don MSN

CVS unit ordered to pay $290M for overcharging Medicare drugs

CVS Health (CVS) stock in focus as its pharmacy benefit manager CVS Caremark faces $289.9M in damages and penalties for ...

Fierce Healthcare2d

Pennsylvania judge hits CVS with $289M fine in whistleblower suit

A Pennsylvania judge has ordered CVS to pay $289 million in damages as part of a long-running whistleblower case. | A ...

Hartford Business Journal4d

CVS Health sells $4B in notes

CVS Health Corp., parent of Hartford-based Aetna Inc., said Friday it has agreed to issue and sell $4 billion in notes.

Zacks Investment Research on MSN7h

CVS Gains in Pharmacy & Consumer Wellness Despite Reimbursement Woes

CVS Health’s CVS Pharmacy & Consumer Wellness (“PCW”) unit includes its retail and long-term care pharmacy operations and related pharmacy services, as well as its retail front store operations. It ...